Treatment refusal and abandonment remain major concerns despite good outcomes with multi-modality management in pediatric medulloblastoma: Experience from a cancer center in Eastern India

Context: Survival in medulloblastoma, the most common pediatric brain tumor, has lagged behind in developing countries in comparison to the West. Aim: The aim of this study was to analyze the clinical profile and outcome in a cancer center in Eastern India. Methods: Twenty-nine children were retrosp...

Full description

Saved in:
Bibliographic Details
Main Authors: Anirban Das, Rimpa Basu Achari, Lateef Zameer, Saugata Sen, Shekhar Krishnan, Arpita Bhattacharyya
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=5;spage=13;epage=15;aulast=Das
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849324551818706944
author Anirban Das
Rimpa Basu Achari
Lateef Zameer
Saugata Sen
Shekhar Krishnan
Arpita Bhattacharyya
author_facet Anirban Das
Rimpa Basu Achari
Lateef Zameer
Saugata Sen
Shekhar Krishnan
Arpita Bhattacharyya
author_sort Anirban Das
collection DOAJ
description Context: Survival in medulloblastoma, the most common pediatric brain tumor, has lagged behind in developing countries in comparison to the West. Aim: The aim of this study was to analyze the clinical profile and outcome in a cancer center in Eastern India. Methods: Twenty-nine children were retrospectively analyzed over 6 years. Results: Vomiting (79%), headache (69%), and unsteadiness (55%) were the presenting complaints. The majority (67%) had classical histology. High-risk (HR) disease (61.6%) exceeded average-risk (AR) (38.4%) disease in numbers. Treatment-refusal (27.6%) and abandonment (6.9%) were major concerns. Four-year EFS was 81% and 52%, excluding and including refusal/abandonment, respectively. There was no relapse/progression among AR patients. Four-year EFS in HR was 63%. Posterior fossa syndrome (37.5%), febrile neutropenia (29%), and ototoxicity (16.7%) were the main treatment-related morbidities. Implications: Following this audit, patient tracking to reduce abandonment, coordination to limit delay in postsurgical referral, developing strategies for molecular subgrouping, and reducing cumulative cisplatin exposure were measures adopted to improve outcome in the unit.
format Article
id doaj-art-a3cf1750afda41df921992a5507299e0
institution Kabale University
issn 0971-5851
0975-2129
language English
publishDate 2019-01-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series Indian Journal of Medical and Paediatric Oncology
spelling doaj-art-a3cf1750afda41df921992a5507299e02025-08-20T03:48:41ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58510975-21292019-01-01405131510.4103/ijmpo.ijmpo_213_17Treatment refusal and abandonment remain major concerns despite good outcomes with multi-modality management in pediatric medulloblastoma: Experience from a cancer center in Eastern IndiaAnirban DasRimpa Basu AchariLateef ZameerSaugata SenShekhar KrishnanArpita BhattacharyyaContext: Survival in medulloblastoma, the most common pediatric brain tumor, has lagged behind in developing countries in comparison to the West. Aim: The aim of this study was to analyze the clinical profile and outcome in a cancer center in Eastern India. Methods: Twenty-nine children were retrospectively analyzed over 6 years. Results: Vomiting (79%), headache (69%), and unsteadiness (55%) were the presenting complaints. The majority (67%) had classical histology. High-risk (HR) disease (61.6%) exceeded average-risk (AR) (38.4%) disease in numbers. Treatment-refusal (27.6%) and abandonment (6.9%) were major concerns. Four-year EFS was 81% and 52%, excluding and including refusal/abandonment, respectively. There was no relapse/progression among AR patients. Four-year EFS in HR was 63%. Posterior fossa syndrome (37.5%), febrile neutropenia (29%), and ototoxicity (16.7%) were the main treatment-related morbidities. Implications: Following this audit, patient tracking to reduce abandonment, coordination to limit delay in postsurgical referral, developing strategies for molecular subgrouping, and reducing cumulative cisplatin exposure were measures adopted to improve outcome in the unit.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=5;spage=13;epage=15;aulast=DasBrain tumordefaulterototoxicityposterior fossa
spellingShingle Anirban Das
Rimpa Basu Achari
Lateef Zameer
Saugata Sen
Shekhar Krishnan
Arpita Bhattacharyya
Treatment refusal and abandonment remain major concerns despite good outcomes with multi-modality management in pediatric medulloblastoma: Experience from a cancer center in Eastern India
Indian Journal of Medical and Paediatric Oncology
Brain tumor
defaulter
ototoxicity
posterior fossa
title Treatment refusal and abandonment remain major concerns despite good outcomes with multi-modality management in pediatric medulloblastoma: Experience from a cancer center in Eastern India
title_full Treatment refusal and abandonment remain major concerns despite good outcomes with multi-modality management in pediatric medulloblastoma: Experience from a cancer center in Eastern India
title_fullStr Treatment refusal and abandonment remain major concerns despite good outcomes with multi-modality management in pediatric medulloblastoma: Experience from a cancer center in Eastern India
title_full_unstemmed Treatment refusal and abandonment remain major concerns despite good outcomes with multi-modality management in pediatric medulloblastoma: Experience from a cancer center in Eastern India
title_short Treatment refusal and abandonment remain major concerns despite good outcomes with multi-modality management in pediatric medulloblastoma: Experience from a cancer center in Eastern India
title_sort treatment refusal and abandonment remain major concerns despite good outcomes with multi modality management in pediatric medulloblastoma experience from a cancer center in eastern india
topic Brain tumor
defaulter
ototoxicity
posterior fossa
url http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=5;spage=13;epage=15;aulast=Das
work_keys_str_mv AT anirbandas treatmentrefusalandabandonmentremainmajorconcernsdespitegoodoutcomeswithmultimodalitymanagementinpediatricmedulloblastomaexperiencefromacancercenterineasternindia
AT rimpabasuachari treatmentrefusalandabandonmentremainmajorconcernsdespitegoodoutcomeswithmultimodalitymanagementinpediatricmedulloblastomaexperiencefromacancercenterineasternindia
AT lateefzameer treatmentrefusalandabandonmentremainmajorconcernsdespitegoodoutcomeswithmultimodalitymanagementinpediatricmedulloblastomaexperiencefromacancercenterineasternindia
AT saugatasen treatmentrefusalandabandonmentremainmajorconcernsdespitegoodoutcomeswithmultimodalitymanagementinpediatricmedulloblastomaexperiencefromacancercenterineasternindia
AT shekharkrishnan treatmentrefusalandabandonmentremainmajorconcernsdespitegoodoutcomeswithmultimodalitymanagementinpediatricmedulloblastomaexperiencefromacancercenterineasternindia
AT arpitabhattacharyya treatmentrefusalandabandonmentremainmajorconcernsdespitegoodoutcomeswithmultimodalitymanagementinpediatricmedulloblastomaexperiencefromacancercenterineasternindia